Glen Harbor Capital Management LLC lowered its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 4.0% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 883,592 shares of the company’s stock after selling 36,652 shares during the period. Express Scripts makes up 1.5% of Glen Harbor Capital Management LLC’s investment portfolio, making the stock its 10th biggest holding. Glen Harbor Capital Management LLC owned about 0.16% of Express Scripts worth $68,222,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Landaas & Co. WI ADV acquired a new position in shares of Express Scripts during the second quarter valued at about $102,000. Kaizen Advisory LLC raised its position in Express Scripts by 147.6% in the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after purchasing an additional 800 shares in the last quarter. Wealthcare Advisory Partners LLC raised its position in Express Scripts by 364.7% in the first quarter. Wealthcare Advisory Partners LLC now owns 1,529 shares of the company’s stock worth $106,000 after purchasing an additional 1,200 shares in the last quarter. Adviser Investments LLC raised its position in Express Scripts by 321.9% in the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after purchasing an additional 1,130 shares in the last quarter. Finally, Sun Life Financial INC raised its position in Express Scripts by 758.8% in the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after purchasing an additional 1,343 shares in the last quarter. 84.73% of the stock is owned by institutional investors and hedge funds.

Several research analysts recently issued reports on ESRX shares. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Tuesday, May 22nd. Robert W. Baird set a $92.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a research report on Thursday, May 17th. Zacks Investment Research raised shares of Express Scripts from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 26th. Royal Bank of Canada increased their price target on shares of Express Scripts to $94.00 and gave the stock an “outperform” rating in a research report on Monday, August 27th. Finally, William Blair raised shares of Express Scripts from a “market perform” rating to an “outperform” rating in a research report on Wednesday, August 1st. Three investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $85.58.

NASDAQ ESRX opened at $86.95 on Wednesday. The company has a market cap of $49.48 billion, a PE ratio of 10.93, a PEG ratio of 1.11 and a beta of 0.99. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. Express Scripts Holding Co has a 1-year low of $55.80 and a 1-year high of $89.60.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.20 by $0.02. The company had revenue of $25.64 billion during the quarter, compared to analyst estimates of $25.43 billion. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The company’s revenue was up 1.2% on a year-over-year basis. During the same quarter last year, the business posted $1.73 earnings per share. equities analysts predict that Express Scripts Holding Co will post 9.07 earnings per share for the current year.

In other news, insider Christine Houston sold 12,898 shares of the firm’s stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the completion of the sale, the insider now owns 110,908 shares of the company’s stock, valued at $9,427,180. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.79% of the company’s stock.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Story: Penny Stocks, What You Need To Know

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.